drugset / Trial / NCT00689299

Phase 2 Study in Adults Sensitized to Cat

NCT00689299

Phase 2 Completed 167 enrolled Antigen Laboratories, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to identify an effective dose of allergen-specific immunotherapy for cat hair (Felis domesticus) administered by the oral/sublingual route.

Timeline

Start
2008-10
Primary completion
2009-05
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cat hair Unknown 0.21 unknown Other
Comparator Cat hair Unknown 2.1 unknown Other

Indications